Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hartmann

Showing results (1001-1010 of 1,037) with videos related to

Pageof 104
Sort By:
Early Intervention in Psychiatry|July 2, 2023
The self, neuroscience and psychosis study: Testing a neurophenomenological model of the onset of psychosisMarija Krcmar, Cassandra M J Wannan, Suzie Lavoie, et al.
Cancer Biology & Therapy|May 12, 2015
8p deletion is strongly linked to poor prognosis in breast cancerP Lebok, A Mittenzwei, M Kluth, et al.
Der Urologe. Ausg. A|September 22, 2019
[Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group]N Ortiz-Brüchle, M Muders, M Toma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expressionU Nitz, O Gluz, J Huober, et al.
NPJ Schizophrenia|June 27, 2018
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical courseB Nelson, G P Amminger, H P Yuen, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Schizophrenia Research|December 24, 2019
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomesS Youn, L J Phillips, G P Amminger, et al.
Psychological Medicine|March 12, 2025
Characterising symptomatic substates in individuals on the psychosis continuum: a hidden Markov modelling approachIsabelle Scott, Emmeke Aarts, Cassandra Wannan, et al.
Journal of Medical Genetics|April 16, 2005
Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancerT Frebourg, C Oliveira, P Hochain, et al.
Behaviour Research and Therapy|December 3, 2019
Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trialJessica A Hartmann, Stefanie J Schmidt, Patrick D McGorry, et al.
Pageof 104

Showing results (1001-1010 of 1,037) with videos related to

Sort By:
Pageof 104
Early Intervention in Psychiatry|July 2, 2023
The self, neuroscience and psychosis study: Testing a neurophenomenological model of the onset of psychosisMarija Krcmar, Cassandra M J Wannan, Suzie Lavoie, et al.
Cancer Biology & Therapy|May 12, 2015
8p deletion is strongly linked to poor prognosis in breast cancerP Lebok, A Mittenzwei, M Kluth, et al.
Der Urologe. Ausg. A|September 22, 2019
[Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group]N Ortiz-Brüchle, M Muders, M Toma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expressionU Nitz, O Gluz, J Huober, et al.
NPJ Schizophrenia|June 27, 2018
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical courseB Nelson, G P Amminger, H P Yuen, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Schizophrenia Research|December 24, 2019
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomesS Youn, L J Phillips, G P Amminger, et al.
Psychological Medicine|March 12, 2025
Characterising symptomatic substates in individuals on the psychosis continuum: a hidden Markov modelling approachIsabelle Scott, Emmeke Aarts, Cassandra Wannan, et al.
Journal of Medical Genetics|April 16, 2005
Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancerT Frebourg, C Oliveira, P Hochain, et al.
Behaviour Research and Therapy|December 3, 2019
Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trialJessica A Hartmann, Stefanie J Schmidt, Patrick D McGorry, et al.
Pageof 104